NCT07023952 Effect of Phenol Addition to Laser Treatment on Epithelialization and Healing Process in Pilonidal Sinus
| NCT ID | NCT07023952 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital |
| Condition | Pilonidal Sinus Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 130 participants |
| Start Date | 2025-05-01 |
| Primary Completion | 2025-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 130 participants in total. It began in 2025-05-01 with a primary completion date of 2025-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study compares two treatment approaches for pilonidal sinus disease: laser treatment alone versus laser treatment combined with phenol application. Pilonidal sinus is a common condition that affects young adults and can cause significant discomfort and time off work. Participants will be randomly assigned to receive either laser treatment only (Group A) or laser treatment plus phenol application (Group B). Both treatments are minimally invasive and performed under local anesthesia as day surgery procedures. The main goal is to determine if adding phenol to laser treatment speeds up the healing process (epithelialization) and improves patient outcomes. We will measure healing time, pain levels, return to daily activities, and quality of life over a 3-month follow-up period. This research may help develop more effective treatment protocols that reduce healing time and improve patient comfort for people with pilonidal sinus disease.
Eligibility Criteria
Inclusion Criteria: * Age 18 years and older * Primary pilonidal sinus disease * Three or fewer pit counts * Willing to participate in the study and signed informed consent form * Able to attend follow-up visits Exclusion Criteria: * Age under 18 years * More than three pit counts * Acute abscess presentation * Bilateral lateral extension * Recurrent pilonidal sinus disease * Immunocompromised patients * Patients unable to attend follow-up visits * Pregnancy (if applicable) * Severe comorbidities that contraindicate surgery under local anesthesia
Frequently Asked Questions
Who can join the NCT07023952 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pilonidal Sinus Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07023952 currently recruiting?
Yes, NCT07023952 is actively recruiting participants. Visit ClinicalTrials.gov or contact Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital to inquire about joining.
Where is the NCT07023952 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07023952 clinical trial?
NCT07023952 is sponsored by Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital. The trial plans to enroll 130 participants.